Acacia Pharma is a wholly owned subsidiary of Eagle Pharmaceuticals offering a portfolio of assets focused on helping improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy.

 

Our products

Acacia Pharma has created a portfolio of differentiated hospital products primarily for use by anesthesia and surgical teams and a promising late-stage development candidate targeting oncologists.

Partnering

thumbnail_partnering.jpeg

Acacia Pharma commercializes its current products directly in the US via its own commercial organization targeting anesthesia and surgical teams.

Partnering

Investors

thumbnail_investors.jpeg

Acacia Pharma is a commercial stage biopharmaceutical group focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy.

Investors